Use of tacrolimus as the primary immunosuppression after renal transplant in native Americans and Hispanics

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1232-1233

  Eghtesad, B ^a   Malhotra, D ^a   Hecker, W P ^a   Haq, M ^a   Gibel, L J ^a   Wheeler, D ^a   Smith, A Y ^a   Harford, A M ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ADULT; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; DOSE RESPONSE; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT INDICATION;

EID: 0031834029     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00222-X     Document Type: Conference Paper

References (6)

1. Koyama H, Cecka JM, Terasaki PI: Transplantation 57(7): 1064, 1994
2. Cecka JM, Gjertson DW, Cho Y, et al: Transplant Proc 25:2446, 1993
3. Lindholm A, Welsh M, Rutzky L, et al: Transplantation 55(5):985, 1993
4. Shapiro R: Transplant Proc 29:45, 1997
5. Woodle ES, Thistlewaite JR, Gordon JH, et al: Transplantation 62:594, 1996
6. Odocha O, McCauley J, Scantlebury V, et al: Transplant Proc 25:2433, 1993